Variability in deceased donor care in Canada : a report of the Canada-DONATE cohort study
PURPOSE: Canadian donor management practices have not been reported. Our aim was to inform clinicians and other stakeholders about the range of current practices.
METHODS: This prospective observational cohort study enrolled consecutive, newly consented organ donors from August 1 2015 to July 31 2018 at 27 academic and five community adult intensive care units in British Columbia, Alberta, Ontario, and Quebec. Research staff prospectively recorded donor management data. Provincial organ donation organizations verified the organs donated. We formally compared practices across provinces.
RESULTS: Over a median collection period of eight months, 622 potential donors were classified at baseline as having neurologic determination of death (NDD donors; n = 403) or circulatory death (DCD donors; n = 219). Among NDD donors, 85.6% underwent apnea testing (rarely with carbon dioxide insufflation), 33.2% underwent ancillary testing, and subsequent therapeutic hypothermia (34-35°C) was rare. Neurologic determination of death donors were more hemodynamically unstable with most having received vasopressin and norepinephrine infusions, with a large majority having received high-dose corticosteroids and intravenous thyroxine. Among DCD donors, 61.6% received corticosteroids, and 8.9% received thyroxine. Most donors did not receive lung-protective ventilation strategies. Invasive procedures after donation consent included bronchoscopy (71.7%), cardiac catheterization (NDD donors only; 21.3%), and blood transfusions (19.3%). Physicians ordered intravenous antemortem heparin for 94.8% of DCD donors. The cohort donated 1,629 organs resulting in 1,532 transplants. Case selection, death determinations, and hormone, nutrition and heparin practices all varied across provinces.
CONCLUSION: These study findings highlight areas for knowledge translation and further clinical research. Interprovincial discrepancies will likely pose unique challenges to national randomized trials.
TRIAL REGISTRATION: www.clinicaltrials.gov (NCT03114436); registered 10 April, 2017.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:67 |
|---|---|
| Enthalten in: |
Canadian journal of anaesthesia = Journal canadien d'anesthesie - 67(2020), 8 vom: 15. Aug., Seite 992-1004 |
| Sprache: |
Englisch |
|---|
| Weiterer Titel: |
Variabilité des soins prodigués aux donneurs décédés au Canada : un compte rendu de l’étude de cohorte Canada-DONATE |
|---|
| Beteiligte Personen: |
D'Aragon, Frédérick [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 19.02.2021 Date Revised 03.01.2024 published: Print-Electronic ClinicalTrials.gov: NCT03114436 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s12630-020-01692-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309690390 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309690390 | ||
| 003 | DE-627 | ||
| 005 | 20240108141516.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12630-020-01692-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1248.xml |
| 035 | |a (DE-627)NLM309690390 | ||
| 035 | |a (NLM)32385825 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a D'Aragon, Frédérick |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Variability in deceased donor care in Canada |b a report of the Canada-DONATE cohort study |
| 246 | 3 | 3 | |a Variabilité des soins prodigués aux donneurs décédés au Canada : un compte rendu de l’étude de cohorte Canada-DONATE |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.02.2021 | ||
| 500 | |a Date Revised 03.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT03114436 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a PURPOSE: Canadian donor management practices have not been reported. Our aim was to inform clinicians and other stakeholders about the range of current practices | ||
| 520 | |a METHODS: This prospective observational cohort study enrolled consecutive, newly consented organ donors from August 1 2015 to July 31 2018 at 27 academic and five community adult intensive care units in British Columbia, Alberta, Ontario, and Quebec. Research staff prospectively recorded donor management data. Provincial organ donation organizations verified the organs donated. We formally compared practices across provinces | ||
| 520 | |a RESULTS: Over a median collection period of eight months, 622 potential donors were classified at baseline as having neurologic determination of death (NDD donors; n = 403) or circulatory death (DCD donors; n = 219). Among NDD donors, 85.6% underwent apnea testing (rarely with carbon dioxide insufflation), 33.2% underwent ancillary testing, and subsequent therapeutic hypothermia (34-35°C) was rare. Neurologic determination of death donors were more hemodynamically unstable with most having received vasopressin and norepinephrine infusions, with a large majority having received high-dose corticosteroids and intravenous thyroxine. Among DCD donors, 61.6% received corticosteroids, and 8.9% received thyroxine. Most donors did not receive lung-protective ventilation strategies. Invasive procedures after donation consent included bronchoscopy (71.7%), cardiac catheterization (NDD donors only; 21.3%), and blood transfusions (19.3%). Physicians ordered intravenous antemortem heparin for 94.8% of DCD donors. The cohort donated 1,629 organs resulting in 1,532 transplants. Case selection, death determinations, and hormone, nutrition and heparin practices all varied across provinces | ||
| 520 | |a CONCLUSION: These study findings highlight areas for knowledge translation and further clinical research. Interprovincial discrepancies will likely pose unique challenges to national randomized trials | ||
| 520 | |a TRIAL REGISTRATION: www.clinicaltrials.gov (NCT03114436); registered 10 April, 2017 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Lamontagne, Francois |e verfasserin |4 aut | |
| 700 | 1 | |a Cook, Deborah |e verfasserin |4 aut | |
| 700 | 1 | |a Dhanani, Sonny |e verfasserin |4 aut | |
| 700 | 1 | |a Keenan, Sean |e verfasserin |4 aut | |
| 700 | 1 | |a Chassé, Michaël |e verfasserin |4 aut | |
| 700 | 1 | |a English, Shane |e verfasserin |4 aut | |
| 700 | 1 | |a Burns, Karen E A |e verfasserin |4 aut | |
| 700 | 1 | |a Frenette, Anne Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Ball, Ian |e verfasserin |4 aut | |
| 700 | 1 | |a Boyd, John Gordon |e verfasserin |4 aut | |
| 700 | 1 | |a Masse, Marie-Hélène |e verfasserin |4 aut | |
| 700 | 1 | |a Breau, Ruth |e verfasserin |4 aut | |
| 700 | 1 | |a Akhtar, Aemal |e verfasserin |4 aut | |
| 700 | 1 | |a Kramer, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Rochwerg, Bram |e verfasserin |4 aut | |
| 700 | 1 | |a Lauzier, François |e verfasserin |4 aut | |
| 700 | 1 | |a Kutsogiannis, Demetrios James |e verfasserin |4 aut | |
| 700 | 1 | |a Ibrahim, Quazi |e verfasserin |4 aut | |
| 700 | 1 | |a Hand, Lori |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Qi |e verfasserin |4 aut | |
| 700 | 1 | |a Meade, Maureen O |e verfasserin |4 aut | |
| 700 | 0 | |a Canadian Critical Care Trials Group and the Canadian Donation and Transplant Research Program |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Canadian journal of anaesthesia = Journal canadien d'anesthesie |d 1987 |g 67(2020), 8 vom: 15. Aug., Seite 992-1004 |w (DE-627)NLM012607282 |x 1496-8975 |7 nnns |
| 773 | 1 | 8 | |g volume:67 |g year:2020 |g number:8 |g day:15 |g month:08 |g pages:992-1004 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12630-020-01692-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 67 |j 2020 |e 8 |b 15 |c 08 |h 992-1004 | ||